SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001437749-22-027772
Filing Date
2022-11-18
Accepted
2022-11-18 17:08:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM PREC14A dffn20221117_prec14a.htm PREC14A 540731
2 card01.jpg GRAPHIC 183622
3 card02.jpg GRAPHIC 758599
4 dffn20221117_prec14aimg001.jpg GRAPHIC 7826
5 dffn20221117_prec14aimg002.jpg GRAPHIC 7339
6 dffn20221117_prec14aimg003.jpg GRAPHIC 7339
  Complete submission text file 0001437749-22-027772.txt   1867877
Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filed by) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902
Business Address 300 EAST MAIN STREET SUITE 201 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Subject) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-37942 | Film No.: 221402745
SIC: 2834 Pharmaceutical Preparations